INSMED Inc (INSM) stock
INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)
Close on Nov 17, 2026Market cap $26.73BP/E –Yield –
Insmed EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Insmed
Insmed has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?